EyePoint Pharmaceuticals, Inc. 8-K

Accession 0000950170-22-024735

Filing information

CIK: 0001314102
Report date: 2022-11-10
Filing date: 2022-11-14
Form: 8-K
Primary document: eypt-20221110.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.